Significant Predictors of Postoperative Morbidity After Radical Resection of Retroperitoneal Sarcoma in a Tertiary Center

[1] Mastrangelo G(2012)Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions Cancer 118 5339-5348

[2] Coindre JM(2021)Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic Australasian RPS working group Ann Surg Oncol 28 7873-7888

[3] Ducimetière F(2020)Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial Lancet Oncol 21 1366-1377

[4] Swallow CJ(2022)Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results Ann Surg. 124 4495-44503

[5] Strauss DC(2018)Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma Cancer 6 2286-2293

[6] Bonvalot S(2019)Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French sarcoma group from the NetSarc database Ann Surg Oncol 19 2981-2891

[7] Bonvalot S(2012)Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG Ann Surg Oncol 27 31-37

[8] Gronchi A(2009)Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control J Clin Oncol 23 1067-1073

[9] Le Péchoux C(2012)Frontline extended surgery is associated with improved survival in retroperitoneal low to intermediate-grade soft tissue sarcomas Ann Oncol. 228 355-365

[10] Callegaro D(1998)Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution Ann Surg 16 S0748-7983

[1] Mastrangelo G(2012)Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions Cancer 118 5339-5348

[2] Coindre JM(2021)Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic Australasian RPS working group Ann Surg Oncol 28 7873-7888

[3] Ducimetière F(2020)Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial Lancet Oncol 21 1366-1377

[4] Swallow CJ(2022)Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results Ann Surg. 124 4495-44503

[5] Strauss DC(2018)Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma Cancer 6 2286-2293

[6] Bonvalot S(2019)Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French sarcoma group from the NetSarc database Ann Surg Oncol 19 2981-2891

[7] Bonvalot S(2012)Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG Ann Surg Oncol 27 31-37

[8] Gronchi A(2009)Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control J Clin Oncol 23 1067-1073

[9] Le Péchoux C(2012)Frontline extended surgery is associated with improved survival in retroperitoneal low to intermediate-grade soft tissue sarcomas Ann Oncol. 228 355-365

[10] Callegaro D(1998)Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution Ann Surg 16 S0748-7983